1
Views
0
CrossRef citations to date
0
Altmetric
Key Paper Evaluation

Expression of activated signal transducer and activator Stat3 as a predictor of poor prognosis in cervical cancer

Pages 161-164 | Published online: 10 Jan 2014
 

Abstract

Evaluation of: Takemoto S, Ushijima K, Kawano K et al. Expression of activated signal transducer and activator of transcription-3 predicts poor prognosis in cervical squamous-cell carcinoma. Br. J. Cancer 101(6), 967–972 (2009).

Stat3 is activated through phosphorylation (p-Stat3), whereupon it enhances the transcription of several molecules involved in cell survival and proliferation. The constitutive activation of Stat3 has been reported in various types of malignancies, and its expression has been shown to indicate a poor prognosis. However, the clinical significance of Stat3 expression in cervical cancer has seldom been evaluated. Using immunohistochemical methods, Takemoto et al. investigated the association between p-Stat3 expression and clinicopathological variables. The expression of p-Stat3 was significantly correlated with stage, tumor size, lymph vascular space invasion and lymph node metastasis. Furthermore, p-Stat3 expression was statistically indicative of a poor prognosis. These data demonstrate the clinical significance of p-Stat3 expression. Continued studies of Stat3 function may help in the development of novel therapeutic strategies for cervical cancer.

Financial & competing interests disclosure

The author has no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

No writing assistance was utilized in the production of this manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.